All Journals > Clinical Infectious Diseases > 15 August 2005 > Fluoroquinolone Use and Resistance

Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

CID LISTED AMONG
“MOST INFLUENTIAL”

Clinical Infectious Diseases has been named as one of the "100 Most Influential Journals in Biology and Medicine" of the past 100 years by the Special Libraries Association. The list was compiled by the 680-plus members of SLA’s Biomedical and Life Sciences Division.

See the full list here.

Source: The DBIO 100, the 100 Most Influential Journals in Biology & Medicine over the last 100 Years

In the News

Featured in MSNBC
"Germs and flu are up; infection control is down" June 9, 2009
Trends in the Incidence of Methicillin‐Resistant Staphylococcus aureus Infection in Children’s Hospitals in the United States
Jeffrey S. Gerber, Susan E. Coffin, Sarah A. Smathers, and Theoklis E. Zaoutis
Just this week, researchers reported that the incidence of MRSA infections among children admitted to pediatric hospitals in the United States more than tripled between 2002 and 2007. Researchers at the Children’s Hospital of Philadelphia and the University of Pennsylvania found cases of MRSA jumped from 6.7 per 1,000 admissions in 2002 to 21.1 cases per 1,000 admissions in 2007, according to a study released online Monday in the journal Clinical Infectious Diseases.

Featured in Toronto Star
"Pigs, viruses and politics" May 2, 2009
Are Swine Workers in the United States at Increased Risk of Infection with Zoonotic Influenza Virus?
Kendall P. Myers, Christopher W. Olsen, Sharon F. Setterquist, Ana W. Capuano, Kelley J. Donham, Eileen L. Thacker, James A. Merchant, and Gregory C. Gray
Another study, this one published in the U.S. journal Clinical Infectious Diseases in 2006, found that workers in meat-processing plants have a greater likelihood of being infected by some version of the H1N1 flu virus than the general population (the odds of pig farmers getting the disease are significantly greater again).

Featured in Philadelphia Inquirer
"A shot in the arm for vaccines" April 19, 2009
Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection
Lisa A. Jackson and Edward N. Janoff
Every year, an estimated 915,000 people 65 and older get pneumonia, and 40 percent of them end up in hospitals, according to a 2004 paper in the journal Clinical Infectious Diseases. Pneumonia often kills older people, said Richard Stefanacci, a geriatrician at the University of the Sciences in Philadelphia.

15 August 2005

Volume 41, Number 4
Clinical Infectious Diseases 2005;41:435–440
© 2005 by the Infectious Diseases Society of America. All rights reserved.
1058-4838/2005/4104-0003$15.00
DOI: 10.1086/432056
MAJOR ARTICLE

Hospital and Community Fluoroquinolone Use and Resistance in Staphylococcus aureus and Escherichia coli in 17 US Hospitals

Conan MacDougall,1

J. Patrick Powell,1

Christopher K. Johnson,3

Michael B. Edmond,2 and

Ronald E. Polk1,2

1School of Pharmacy, Department of Pharmacy, and 2School of Medicine, Department of Internal Medicine, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, Virginia; and 3College of Pharmacy, Department of Pharmacy Practice, Idaho State University, Boise

Background.Fluoroquinolones are widely prescribed in hospitals and the community. Previous studies have shown associations between fluoroquinolone use and isolation of fluoroquinolone‐resistant Eshcerichia coli and methicillin‐resistant Staphylococcus aureus (MRSA). We performed an ecologic‐level study to determine whether variability in hospital percentages of fluoroquinolone‐resistant E. coli and MRSA were associated with fluoroquinolone use in hospitals and their surrounding communities.

Methods.We measured fluoroquinolone use in 17 US hospitals and their surrounding communities in the year 2000. Data on fluoroquinolone use in hospitals was electronically extracted from billing data. Data on fluoroquinolone use in communities was obtained from IMS health data for all prescriptions filled in pharmacies within a 16‐km radius of each hospital. We used hospital antibiograms to determine the percentage of isolates that were fluoroquinolone‐resistant E. coli and MRSA, and we performed linear regression to determine the relationship between percentage of resistant isolates and fluoroquinolone use in hospitals and their surrounding communities.

Results.There was a significant association between total fluoroquinolone use within hospitals and percentage of S. aureus isolates that were MRSA ( ; ) and between total fluoroquinolone use in the community and percentage of E. coli isolates that were fluoroquinolone‐resistant E. coli ( ; ). Population density within the 16‐km radius also correlated with MRSA percentage ( ; ) and fluoroquinolone‐resistant E. coli percentage ( ; ), but associations between total fluoroquinolone use and resistance remained significant after adjustment for population density.

Conclusions.In this ecologic analysis, we found associations between fluoroquinolone use in hospitals and methicillin resistance in S. aureus and between fluoroquinolone use in communities and fluoroquinolone resistance in E. coli in hospitals. Antimicrobial use in hospitals and communities may have different relative importance with regard to resistance in different pathogens encountered in hospitals.

Received 7 December 2004; accepted 6 April 2005; electronically published 28 June 2005.

Reprints or correspondence: Dr. Ronald E. Polk, 410 N. 12th St., Rm. 454, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, VA 23298 ().

Cited by

M. N. Al-Hasan, B. D. Lahr, J. E. Eckel-Passow, L. M. Baddour. (2009) Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007. Journal of Antimicrobial Chemotherapy 64:1, 169-174
Online publication date: 1-Aug-2009.
CrossRef
Richard H Drew, Roger White, Conan MacDougall, Elizabeth D Hermsen, Robert C Owens, . (2009) Insights from the Society of Infectious Diseases Pharmacists on Antimicrobial Stewardship Guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Pharmacotherapy 29:5, 593-607
Online publication date: 1-Jun-2009.
CrossRef
Klaus Kaier, Dipl‐Vw; Christian Hagist, PhD; Uwe Frank, MD; Andreas Conrad, MD; Elisabeth Meyer, MD. (2009) Two Time‐Series Analyses of the Impact of Antibiotic Consumption and Alcohol‐Based Hand Disinfection on the Incidences of Nosocomial Methicillin‐Resistant Staphylococcus aureus Infection and Clostridium difficile Infection •. Infection Control and Hospital Epidemiology 30:4, 346-353
Online publication date: 1-Apr-2009.
Abstract-Full Text-PDF Version (505 kB)
K. Kaier, U. Frank, C. Hagist, A. Conrad, E. Meyer. (2009) The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum  -lactamase-producing strains: a time-series analysis. Journal of Antimicrobial Chemotherapy 63:3, 609-614
Online publication date: 15-Feb-2009.
CrossRef
By Paul P. Cook, MD; Titu D. Das, MD, MPH; Michael Gooch, RPh; Paul G. Catrou, MD. (2008) Effect of a Program to Reduce Hospital Ciprofloxacin Use on Nosocomial Pseudomonas aeruginosa Susceptibility to Quinolones and Other Antimicrobial Agents. Infection Control and Hospital Epidemiology 29:8, 716-722
Online publication date: 1-Aug-2008.
Abstract-Full Text-PDF Version (170 kB)
Amy Pakyz, J. Patrick Powell, Spencer E Harpe, Chris Johnson, Michael Edmond, Ron E Polk. (2008) Diversity of Antimicrobial Use and Resistance in 42 Hospitals in the United States. Pharmacotherapy 28:7, 906-912
Online publication date: 1-Aug-2008.
CrossRef
By Elias Iosifidis, MD; Charalampos Antachopoulos, MD, PhD; Maria Tsivitanidou, MD; Aspasia Katragkou, MD; Evagelia Farmaki, MD, PhD; Maria Tsiakou, MD; Theano Kyriazi, MSc; Danai Sofianou, MD, PhD; Emmanuel Roilides, MD, PhD. (2008) Differential Correlation Between Rates of Antimicrobial Drug Consumption and Prevalence of Antimicrobial Resistance in a Tertiary Care Hospital in Greece. Infection Control and Hospital Epidemiology 29:7, 615-622
Online publication date: 1-Jul-2008.
Abstract-Full Text-PDF Version (204 kB)
I. Shalit, M. Low, E. Levy, M. Chowers, O. Zimhony, K. Riesenberg, J. Bishara, R. Raz. (2008) Antibiotic use in 26 departments of internal medicine in 6 general hospitals in Israel: variability and contributing factors. Journal of Antimicrobial Chemotherapy 62:1, 196-204
Online publication date: 1-May-2008.
CrossRef
Alison Freifeld, Jayashri Sankaranarayanan, Fred Ullrich, Junfeng Sun. (2008) Clinical practice patterns of managing low-risk adult febrile neutropenia during cancer chemotherapy in the USA. Supportive Care in Cancer 16:2, 181-191
Online publication date: 1-Mar-2008.
CrossRef
Amy L Pakyz. (2007) The Utility of Hospital Antibiograms as Tools for Guiding Empiric Therapy and Tracking Resistance. Pharmacotherapy 27:9, 1306-1312
Online publication date: 1-Oct-2007.
CrossRef
Andrew F. Shorr. (2007) Epidemiology of Staphylococcal Resistance. Clinical Infectious Diseases 45:s3, S171-S176
Online publication date: 15-Sep-2007.
Abstract-Full Text-PDF Version (322 kB)
Kathryn J. Eagye, Joseph L. Kuti, David P. Nicolau. (2007) Evaluating Empiric Treatment Options for Secondary Peritonitis Using Pharmacodynamic Profiling. Surgical Infections 8:2, 215-226
Online publication date: 1-May-2007.
CrossRef
Akira Yamamoto, Ichiro Konishi, Masahiro Kumata. (2007) Drug-resistant bacteria isolated from pharyngeal swab cultures and urine in acutely or chronically febrile elderly nursing home inmates. Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 44:3, 331-338
Online publication date: 1-Feb-2007.
CrossRef
Su Young Lee, Hong Wei Fan, Christina Sutherland, Andrew C DeRyke, David P Nicolau. (2007) Antibacterial Effects of Moxifloxacin and Levofloxacin Simulating Epithelial Lining Fluid Concentrations against Community-Acquired Methicillin-Resistant Staphylococcus aureus. Drugs in R & D 8:2, 69-77
Online publication date: 1-Feb-2007.
CrossRef
Su Young Lee, Joseph L. Kuti, David P. Nicolau. (2006) Empiric Pharmacodynamic Performance of 9 Antimicrobials Against Pathogens Implicated in the Cause of Complicated Skin and Soft Tissue Infections. Infectious Diseases in Clinical Practice 14:5, 289-295
Online publication date: 1-Oct-2006.
CrossRef
Stephen Brunton. (2006) Overcoming and containing bacterial resistance: appropriate antibiotic use in community-acquired RTIs. Therapy 3:4, 527-533
Online publication date: 1-Aug-2006.
CrossRef
Bala Hota. (2006) Editorial Commentary: Infection Control or Formulary Control: What Is the Best Tool to Reduce Nosocomial Infections due to Methicillin‐Resistant Staphylococcus aureus?. Clinical Infectious Diseases 42:6, 785-787
Online publication date: 15-Mar-2006.
Citation-Full Text-PDF Version (58 kB)
Pierre Charbonneau, Jean‐Jacques Parienti, Pascal Thibon, Michel Ramakers, Cédric Daubin, Damien du Cheyron, Guy Lebouvier, Xavier Le Coutour, and Roland Leclercq, for the French Fluoroquinolone Free (3F) Study Group. (2006) Fluoroquinolone Use and Methicillin‐Resistant Staphylococcus aureus Isolation Rates in Hospitalized Patients: A Quasi Experimental Study. Clinical Infectious Diseases 42:6, 778-784
Online publication date: 15-Mar-2006.
Abstract-Full Text-PDF Version (533 kB)
Louis B. Rice. (2005) Snapshots for November 2005. Infectious Diseases in Clinical Practice 13:6, 286-287
Online publication date: 1-Dec-2005.
CrossRef
Back to Top
Close Popup